NanoString Technologies sank 50% amid heavy trading after the company said it withdrew Q4 and full-year 2023 financial guidance pending a review of the impact of a litigation on its business.
TD.
Health care stocks were slightly down premarket Monday as the Health Care Select Sector SPDR Fund was flat, while the iShares Biotechnology ETF was marginally down.
In company news, NanoString.
NanoString stock unravels after losing $31M patent verdict to 10x Genomics fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
10x Genomics (TXG) Wins Patent Infringement Case Against NanoString Technologies (NSTG) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.